Protein Tyrosine Phosphatase 1B Attenuates Growth Hormone-Mediated JAK2-STAT Signaling

REFERENCES

• Aoki, N., and T. Matsuda. 2000. A cytosolic protein-tyrosine phosphatase PTP1B specifically dephosphorylates and deactivates prolactin-activated STAT5a and STAT5b. J. Biol. Chem. 275: 39718–39726.
   PubMedGoogle Scholar
• Aoki, N., and T. Matsuda. 2002. A nuclear protein tyrosine phosphatase TC-PTP is a potential negative regulator of the PRL-mediated signaling pathway: dephosphorylation and deactivation of signal transducer and activator of transcription 5a and 5b by TC-PTP in nucleus. Mol. Endocrinol. 16: 58–69.
   PubMedGoogle Scholar
• Argetsinger, L. S., G. S. Campbell, X. Yang, B. A. Witthuhn, O. Silvennoinen, J. N. Ihle, and C. Carter-Su. 1993. Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase. Cell 74: 237–244.
   PubMed Web of Science ®Google Scholar
• Beauloye, V., B. Willems, V. de Coninck, S. J. Frank, M. Edery, and J. P. Thissen. 2002. Impairment of liver GH receptor signaling by fasting. Endocrinology 143: 792–800.
   PubMedGoogle Scholar
• Boisclair, Y. R., J. Wang, J. Shi, K. R. Hurst, and G. T. Ooi. 2000. Role of the suppressor of cytokine signaling-3 in mediating the inhibitory effects of interleukin-1β on the growth hormone-dependent transcription of the acid-labile subunit gene in liver cells. J. Biol. Chem. 275: 3841–3847.
   PubMedGoogle Scholar
• Butler, A. A., and D. Le Roith. 2001. Control of growth by the somatropic axis: growth hormone and the insulin-like growth factors have related and independent roles. Annu. Rev. Physiol. 63: 141–164.
   PubMed Web of Science ®Google Scholar
• Charest, A., J. Wagner, S. H. Shen, and M. L. Tremblay. 1995. Murine protein tyrosine phosphatase-PEST, a stable cytosolic protein tyrosine phosphatase. Biochem. J. 308: 425–432.
   PubMedGoogle Scholar
• Cheng, A., G. S. Bal, B. P. Kennedy, and M. L. Tremblay. 2001. Attenuation of adhesion-dependent signaling and cell spreading in transformed fibroblasts lacking protein tyrosine phosphatase-1B. J. Biol. Chem. 276: 25848–25855.
   PubMedGoogle Scholar
• Cheng, A., N. Dube, F. Gu, and M. L. Tremblay. 2002. Coordinated action of protein tyrosine phosphatases in insulin signal transduction Eur. J. Biochem. 269: 1050–1059.
   Google Scholar
• Cheng, A., N. Uetani, P. D. Simoncic, V. P. Chaubey, A. Lee-Loy, C. J. McGlade, B. P. Kennedy, and M. L. Tremblay. 2002. Attenuation of leptin action and regulation of obesity by protein tyrosine phosphatase 1B. Dev. Cell 2: 497–503.
   PubMed Web of Science ®Google Scholar
• Efstratiadis, A. 1998. Genetics of mouse growth. Int. J. Dev. Biol. 42: 955–976.
   PubMed Web of Science ®Google Scholar
• Elchebly, M., P. Payette, E. Michaliszyn, W. Cromlish, S. Collins, A. L. Loy, D. Normandin, A. Cheng, J. Himms-Hagen, C. C. Chan, C. Ramachandran, M. J. Gresser, M. L. Tremblay, and B. P. Kennedy. 1999. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science 283: 1544–1548.
   PubMed Web of Science ®Google Scholar
• Flint, A. J., T. Tiganis, D. Barford, and N. K. Tonks. 1997. Development of “substrate-trapping” mutants to identify physiological substrates of protein tyrosine phosphatases. Proc. Natl. Acad. Sci. USA 94: 1680–1685.
   PubMed Web of Science ®Google Scholar
• Flores-Morales, A., L. Fernandez, E. Rico-Bautista, A. Umana, C. Negrin, J. G. Zhang, and G. Norstedt. 2001. Endoplasmic reticulum stress prolongs GH-induced Janus kinase (JAK2)/signal transducer and activator of transcription (STAT5) signaling pathway. Mol. Endocrinol. 15: 1471–1483.
   PubMedGoogle Scholar
• Frangioni, J. V., P. H. Beahm, V. Shifrin, C. A. Jost, and B. G. Neel. 1992. The nontransmembrane tyrosine phosphatase PTP-1B localizes to the endoplasmic reticulum via its 35 amino acid C-terminal sequence. Cell 68: 545–560.
   PubMed Web of Science ®Google Scholar
• Frank, S. J. 2001. Growth hormone signalling and its regulation: preventing too much of a good thing. Growth Horm. IGF Res. 11: 201–212.
   PubMed Web of Science ®Google Scholar
• Greenhalgh, C. J., P. Bertolino, S. L. Asa, D. Metcalf, J. E. Corbin, T. E. Adams, H. W. Davey, N. A. Nicola, D. J. Hilton, and W. S. Alexander. 2002. Growth enhancement in suppressor of cytokine signaling 2 (SOCS-2)-deficient mice is dependent on signal transducer and activator of transcription 5b (STAT5b). Mol. Endocrinol. 16: 1394–1406.
   PubMed Web of Science ®Google Scholar
• Greenhalgh, C. J., and D. J. Hilton. 2001. Negative regulation of cytokine signaling. J. Leukoc. Biol. 70: 348–356.
   PubMed Web of Science ®Google Scholar
• Gronowski, A. M., and P. Rotwein. 1994. Rapid changes in nuclear protein tyrosine phosphorylation after growth hormone treatment in vivo. Identification of phosphorylated mitogen-activated protein kinase and STAT91. J. Biol. Chem. 269: 7874–7878.
   PubMedGoogle Scholar
• Hackett, R. H., Y. D. Wang, S. Sweitzer, G. Feldman, W. I. Wood, and A. C. Larner. 1997. Mapping of a cytoplasmic domain of the human growth hormone receptor that regulates rates of inactivation of Jak2 and Stat proteins. J. Biol. Chem. 272: 11128–11132.
   PubMedGoogle Scholar
• Haj, F. G., P. J. Verveer, A. Squire, B. G. Neel, and P. I. Bastiaens. 2002. Imaging sites of receptor dephosphorylation by PTP1B on the surface of the endoplasmic reticulum. Science 295: 1708–1711.
   PubMed Web of Science ®Google Scholar
• Herrington, J., and C. Carter-Su. 2001. Signaling pathways activated by the growth hormone receptor. Trends Endocrinol. Metab. 12: 252–257.
   PubMed Web of Science ®Google Scholar
• Horvat, S., and J. F. Medrano. 2001. Lack of Socs2 expression causes the high-growth phenotype in mice. Genomics 72: 209–212.
   PubMedGoogle Scholar
• Ibarra-Sanchez, M. J., J. Wagner, M. T. Ong, C. Lampron, and M. L. Tremblay. 2001. Murine embryonic fibroblasts lacking TC-PTP display delayed G1 phase through defective NF-κB activation. Oncogene 20: 4728–4739.
   PubMedGoogle Scholar
• Irie-Sasaki, J., T. Sasaki, W. Matsumoto, A. Opavsky, M. Cheng, G. Welstead, E. Griffiths, C. Krawczyk, C. D. Richardson, K. Aitken, N. Iscove, G. Koretzky, P. Johnson, P. Liu, D. M. Rothstein, and J. M. Penninger. 2001. CD45 is a JAK phosphatase and negatively regulates cytokine receptor signalling. Nature 409: 349–354.
   PubMed Web of Science ®Google Scholar
• Jiao, H., K. Berrada, W. Yang, M. Tabrizi, L. C. Platanias, and T. Yi. 1996. Direct association with and dephosphorylation of Jak2 kinase by the SH2-domain-containing protein tyrosine phosphatase SHP-1. Mol. Cell. Biol. 16: 6985–6992.
   PubMed Web of Science ®Google Scholar
• Johnston, J. A., M. Kawamura, R. A. Kirken, Y. Q. Chen, T. B. Blake, K. Shibuya, J. R. Ortaldo, D. W. McVicar, and J. J. O'Shea. 1994. Phosphorylation and activation of the Jak-3 Janus kinase in response to interleukin-2. Nature 370: 151–153.
   PubMed Web of Science ®Google Scholar
• Kim, S. O., J. Jiang, W. Yi, G. S. Feng, and S. J. Frank. 1998. Involvement of the Src homology 2-containing tyrosine phosphatase SHP-2 in growth hormone signaling. J. Biol. Chem. 273: 2344–2354.
   PubMedGoogle Scholar
• Klaman, L. D., O. Boss, O. D. Peroni, J. K. Kim, J. L. Martino, J. M. Zabolotny, N. Moghal, M. Lubkin, Y. B. Kim, A. H. Sharpe, A. Stricker-Krongrad, G. I. Shulman, B. G. Neel, and B. B. Kahn. 2000. Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice. Mol. Cell. Biol. 20: 5479–5489.
   PubMed Web of Science ®Google Scholar
• Kopchick, J. J., L. L. Bellush, and K. T. Coschigano. 1999. Transgenic models of growth hormone action. Annu. Rev. Nutr. 19: 437–461.
   PubMedGoogle Scholar
• Lang, C. H., X. Liu, G. J. Nystrom, and R. A. Frost. 2000. Acute response of IGF-I and IGF binding proteins induced by thermal injury. Am. J. Physiol. Endocrinol. Metab. 278: E1087–E1096.
   PubMedGoogle Scholar
• Lavoie, C., E. Chevet, L. Roy, N. K. Tonks, A. Fazel, B. I. Posner, J. Paiement, and J. J. Bergeron. 2000. Tyrosine phosphorylation of p97 regulates transitional endoplasmic reticulum assembly in vitro. Proc. Natl. Acad. Sci. USA 97: 13637–13642.
   PubMedGoogle Scholar
• Lebrun, J. J., S. Ali, A. Ullrich, and P. A. Kelly. 1995. Proline-rich sequence-mediated Jak2 association to the prolactin receptor is required but not sufficient for signal transduction. J. Biol. Chem. 270: 10664–10670.
   PubMedGoogle Scholar
• Le Roith, D., C. Bondy, S. Yakar, J. L. Liu, and A. Butler. 2001. The somatomedin hypothesis: 2001. Endocr. Rev. 22: 53–74.
   PubMed Web of Science ®Google Scholar
• Lupu, F., J. D. Terwilliger, K. Lee, G. V. Segre, and A. Efstratiadis. 2001. Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth. Dev. Biol. 229: 141–162.
   PubMed Web of Science ®Google Scholar
• Mao, Y., P. R. Ling, T. P. Fitzgibbons, K. C. McCowen, G. P. Frick, B. R. Bistrian, and R. J. Smith. 1999. Endotoxin-induced inhibition of growth hormone receptor signaling in rat liver in vivo. Endocrinology 140: 5505–5515.
   PubMedGoogle Scholar
• Metcalf, D., C. J. Greenhalgh, E. Viney, T. A. Willson, R. Starr, N. A. Nicola, D. J. Hilton, and W. S. Alexander. 2000. Gigantism in mice lacking suppressor of cytokine signalling-2. Nature 405: 1069–1073.
   PubMed Web of Science ®Google Scholar
• Myers, M. P., J. N. Andersen, A. Cheng, M. L. Tremblay, C. M. Horvath, J. P. Parisien, A. Salmeen, D. Barford, and N. K. Tonks. 2001. TYK2 and JAK2 are substrates of protein-tyrosine phosphatase 1B. J. Biol. Chem. 276: 47771–47774.
   PubMed Web of Science ®Google Scholar
• Ooi, G. T., K. R. Hurst, M. N. Poy, M. M. Rechler, and Y. R. Boisclair. 1998. Binding of STAT5a and STAT5b to a single element resembling a gamma-interferon-activated sequence mediates the growth hormone induction of the mouse acid-labile subunit promoter in liver cells. Mol. Endocrinol. 12: 675–687.
   PubMedGoogle Scholar
• Pitot, H. C., C. Peraino, P. A. Morse, and V. A. Potter. 1964. Hepatoma in tissue culture compared with adapting liver in vitro. Natl. Cancer Inst. Monogr. 13: 229–242.
   PubMedGoogle Scholar
• Salmeen, A., J. N. Andersen, M. P. Myers, N. K. Tonks, and D. Barford. 2000. Molecular basis for the dephosphorylation of the activation segment of the insulin receptor by protein tyrosine phosphatase 1B. Mol. Cell 6: 1401–1412.
   PubMed Web of Science ®Google Scholar
• Simoncic, P. D., A. Lee-Loy, D. L. Barber, M. L. Tremblay, and C. J. McGlade. 2002. The T cell protein tyrosine phosphatase is a negative regulator of janus family kinases 1 and 3. Curr. Biol. 12: 446–453.
   Google Scholar
• Smit, L. S., D. J. Meyer, N. Billestrup, G. Norstedt, J. Schwartz, and C. Carter-Su. 1996. The role of the growth hormone (GH) receptor and JAK1 and JAK2 kinases in the activation of Stats 1, 3, and 5 by GH. Mol. Endocrinol. 10: 519–533.
   PubMedGoogle Scholar
• Sonksen, P. H., F. Salomon, and R. Cuneo. 1991. Metabolic effects of hypopituitarism and acromegaly. Horm. Res. 36: 27–31.
   PubMedGoogle Scholar
• Starr, R., T. A. Willson, E. M. Viney, L. J. Murray, J. R. Rayner, B. J. Jenkins, T. J. Gonda, W. S. Alexander, D. Metcalf, N. A. Nicola, and D. J. Hilton. 1997. A family of cytokine-inducible inhibitors of signalling. Nature 387: 917–921.
   PubMed Web of Science ®Google Scholar
• Stofega, M. R., J. Herrington, N. Billestrup, and C. Carter-Su. 2000. Mutation of the SHP-2 binding site in growth hormone (GH) receptor prolongs GH-promoted tyrosyl phosphorylation of GH receptor, JAK2, and STAT5B. Mol. Endocrinol. 14: 1338–1350.
   PubMed Web of Science ®Google Scholar
• Taghibiglou, C., F. Rashid-Kolvear, S. C. Van Iderstine, H. Le-Tien, I. G. Fantus, G. F. Lewis, and K. Adeli. 2002. Hepatic very low density lipoprotein-ApoB overproduction is associated with attenuated hepatic insulin signaling and overexpression of protein-tyrosine phosphatase 1B in a fructose-fed hamster model of insulin resistance. J. Biol. Chem. 277: 793–803.
   PubMed Web of Science ®Google Scholar
• ten Hoeve, J., M. de Jesus Ibarra-Sanchez, Y. Fu, W. Zhu, M. Tremblay, M. David, and K. Shuai. 2002. Identification of a nuclear Sstat1 protein tyrosine phosphatase. Mol. Cell. Biol. 22: 5662–5668.
   PubMed Web of Science ®Google Scholar
• Thissen, J. P., L. E. Underwood, and J. M. Ketelslegers. 1999. Regulation of insulin-like growth factor-I in starvation and injury. Nutr. Rev. 57: 167–176.
   PubMed Web of Science ®Google Scholar
• Tonks, N. K., and B. G. Neel. 2001. Combinatorial control of the specificity of protein tyrosine phosphatases. Curr. Opin. Cell Biol. 13: 182–195.
   PubMed Web of Science ®Google Scholar
• Xu, X., S. A. Bennett, R. L. Ingram, and W. E. Sonntag. 1995. Decreases in growth hormone receptor signal transduction contribute to the decline in insulin-like growth factor I gene expression with age. Endocrinology 136: 4551–4557.
   PubMedGoogle Scholar
• You-Ten, K. E., E. S. Muise, A. Itie, E. Michaliszyn, J. Wagner, S. Jothy, W. S. Lapp, and M. L. Tremblay. 1997. Impaired bone marrow microenvironment and immune function in T cell protein tyrosine phosphatase-deficient mice. J. Exp. Med. 186: 683–693.
   PubMed Web of Science ®Google Scholar
• Zabolotny, J. M., K. K. Bence-Hanulec, A. Stricker-Krongrad, F. Haj, Y. Wang, Y. Minokoshi, Y. B. Kim, J. K. Elmquist, L. A. Tartaglia, B. B. Kahn, and B. G. Neel. 2002. PTP1B regulates leptin signal transduction in vivo. Dev. Cell 2: 489–495.
   PubMed Web of Science ®Google Scholar